Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 7,441-7,452 of 10,612

Drug study icon

CompletedNCT01786239

Omega-3 Dietary Supplements in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, BipolarityDrugFrom 15 Years to 40 Years

Countries: United States
Sponsor: Delbert Robinson
Condition: Schizophrenia, Bipolarity

Drug study icon

TerminatedNCT00592683

Omega-3 Fatty Acid Adjunctive to Aripiprazole for Bipolarity in Children and Adolescents

This study was terminated in the United States. It focuses on Bipolarity.

In United States

BipolarityDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Bipolarity

Behavioral study icon

CompletedNCT00585390

Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 8 Years to 25 Years

Countries: United States
Sponsor: University of Cincinnati
Condition: Schizophrenia

Drug study icon

CompletedNCT01399827

Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: ADHD

Drug study icon

CompletedNCT00833976

Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, BipolarityDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Schizophrenia, Bipolarity

Drug study icon

CompletedNCT00644423

Omega-3 Fatty Acids and PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Durham VA Medical Center
Condition: PTSD

Drug study icon

TerminatedNCT01778647

Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 15 Years

Countries: United States
Sponsor: Antonios Likourezos
Condition: ADHD

Drug study icon

CompletedNCT04417595

Omega-3 Fatty Acids for Smoking Cessation in Pregnancy

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 16 Years to 40 Years

Countries: United States
Sponsor: Vanderbilt University Medical Center
Condition: Addiction

Drug study icon

CompletedNCT00010868

Omega-3 Fatty Acids in Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: National Center for Complementary and Integrative Health (NCCIH)
Condition: Bipolarity

Drug study icon

CompletedNCT00252486

Omega-3 Fatty Acids in Children and Adolescents With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: University of Rochester
Condition: Bipolarity

Drug study icon

CompletedNCT00001146

Omega-3 Fatty Acids in the Treatment of Bipolarity: A study

This study is completed in the United States. It focuses on Bipolarity.

In United States

Bipolarity, DepressionDrug

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT01315327

Omega-3 Fatty Acids in Tourette's Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 6 Years to 18 Years

Countries: United States
Sponsor: NYU Langone Health
Condition: OCD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.